Medicare Enrolled

Dr. Dennis Costa, M.D.

Medical Oncology · Lewisville, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
2790 LAKE VISTA DR, Lewisville, TX 75067
9724591300
In practice since 2006 (19 years)
NPI: 1083652291 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Costa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Costa? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Costa

Dr. Dennis Costa is a medical oncology in Lewisville, TX, with 19 years in practice. Based on federal Medicare data, Dr. Costa performed 31,425 Medicare services across 4,290 unique beneficiaries.

Between the years covered by Open Payments, Dr. Costa received a total of $2,980 from 44 pharmaceutical and/or device companies across 132 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Costa is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 29% volume in TX$ $2,980 industry payments

Medicare Practice Summary

Medicare Utilization ↗
31,425
Medicare services
Top 29% in TX for medical oncology
4,290
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,654 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron sucrose injection (Venofer)16,800$0$2
Contrast dye for imaging (iodine-based)2,695$0$3
Blood draw (venipuncture)1,523$8$20
Denosumab injection (Prolia/Xgeva)1,200$18$66
Complete blood count (CBC) with differential1,194$8$36
Comprehensive metabolic blood panel1,117$10$64
Iron level test534$6$27
Iron binding capacity test534$9$35
Ferritin level test (iron stores)531$13$60
Prothrombin time test (blood clotting)435$4$30
Office visit, established patient, complex (40-54 min)423$126$496
Folic acid level test362$14$73
Vitamin B-12 level test360$15$76
Lactate dehydrogenase (enzyme) level341$6$31
Thyroid stimulating hormone (TSH) test285$16$80
Thyroid hormone evaluation271$6$30
Thyroxine (thyroid chemical), total267$7$32
Magnesium level test266$7$29
Vitamin D level test247$29$250
Dexamethasone injection (steroid)225$0$1
Uric acid level test206$4$25
Phosphate level test203$5$24
Anti-nausea injection (Aloxi/palonosetron)190$1$114
Office visit, established patient (30-39 min)164$85$368
Drug injection, under skin or into muscle133$10$96
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less122$48$313
Complete blood count (CBC), automated87$6$34
Microscopic examination for white blood cells with manual cell count86$4$22
Hospital follow-up visit, high complexity73$88$357
Injection, zoledronic acid, 1 mg64$7$431
Immunoglobulin level test56$9$56
Red blood count automated, with additional calculations56$5$26
Injection of additional new drug or substance into vein48$12$108
Administration of chemotherapy into vein, 1 hour or less45$98$707
Measurement of immunoglobulin light chains44$17$60
Irrigation of implanted venous access drug delivery device34$17$114
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries29$91$657
Nuclear medicine study from skull base to mid-thigh with ct scan28$1,112$4,802
Reticulated (young) platelet measurement26$35$143
CT scan of abdomen and pelvis with contrast24$175$1,067
Ct scan of chest with contrast23$43$821
Office visit, established patient (20-29 min)23$62$250
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less22$22$157
Manual urinalysis test with examination using microscope, non-automated15$4$26
Drawing of blood for a medical problem14$73$264
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
68.3% medium
31.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,980
Total received (2018-2024)
Avg $426/year across 7 years
Bottom 46% in TX for medical oncology
44
Companies
132
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,836 (95.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$144 (4.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$998
2023
$599
2022
$458
2021
$41
2020
$167
2019
$338
2018
$381

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$281
Astellas Pharma US Inc
$182
Genentech USA, Inc.
$158
JAZZ PHARMACEUTICALS INC.
$154
Puma Biotechnology, Inc.
$150
Pharmacyclics LLC, An AbbVie Company
$149
Novartis Pharmaceuticals Corporation
$137
Amgen Inc.
$121
PharmaEssentia USA Corporation
$119
Janssen Biotech, Inc.
$114
ABBVIE INC.
$104
Celgene Corporation
$97
Merck Sharp & Dohme LLC
$96
Incyte Corporation
$85
E.R. Squibb & Sons, L.L.C.
$80
Bayer Healthcare Pharmaceuticals Inc.
$69
Adaptive Biotechnologies Corporation
$66
Kite Pharma, Inc.
$60
AVEO Pharmaceuticals, Inc.
$57
Daiichi Sankyo Inc.
$57
AstraZeneca Pharmaceuticals LP
$50
Eisai Inc.
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
Exelixis Inc.
$42
TAIHO ONCOLOGY, INC.
$37
Merck Sharp & Dohme Corporation
$35
Dendreon Pharmaceuticals LLC
$34
PUMA BIOTECHNOLOGY, INC.
$34
CTI BioPharma Corp.
$33
Seagen Inc.
$33
Karyopharm Therapeutics Inc.
$31
SOBI, INC
$30
Blueprint Medicines Corporation
$26
HEMA Biologics, LLC
$23
Accord Healthcare, Inc.
$17
Epizyme, Inc.,
$17
Genmab U.S., Inc.
$16
Ipsen Biopharmaceuticals, Inc
$16
MEDIVATION FIELD SOLUTIONS LLC
$15
TESARO, Inc.
$14
Clovis Oncology, Inc.
$12
Gilead Sciences, Inc.
$12
Array BioPharma Inc.
$12
GENZYME CORPORATION
$11
Top 3 companies account for 20.9% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Abraxane · Alecensa · BESREMI · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · Cabometyx · DARZALEX · ELAHERE · EMPLICITI · ENHERTU · EPKINLY · Enhertu · Epkinly · Erleada · FOTIVDA · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · INLYTA · Imbruvica · JAKAFI · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · Nerlynx · Nplate · Nubeqa · OPDIVO · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Polivy · Pomalyst · REBLOZYL · Rubraca · SCEMBLIX · SUTENT · SevenFact · Somatuline Depot · Stivarga · TASIGNA · TAZVERIK · TECENTRIQ · TUKYSA · VENCLEXTA · VONJO · Venclexta · Vonjo · XALKORI · XPOVIO · XTANDI · Xtandi · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $9 per 100 Medicare services performed
Looking for a medical oncology in Lewisville?
Compare medical oncologys in the Lewisville area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
82
Per 100K population
8.7
County median income
$108,185
Nearest hospital
MEDICAL CITY LEWISVILLE
2.8 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Costa is a mixed practice specialist, with above-average Medicare volume (top 29% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Costa experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Costa performed 16,800 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Costa receive payments from pharmaceutical companies?
Yes. Dr. Costa received a total of $2,980 from 44 companies across 132 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Costa's costs compare to other medical oncologys in Lewisville?
Dr. Costa's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Costa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →